IRLAB Therapeutics Receives US Patent Allowance for Parkinson’s Candidate IRL1117
IRLAB Therapeutics says its Parkinson’s drug candidate IRL1117 has received a US patent allowance.
IRLAB Therapeutics says its Parkinson’s drug candidate IRL1117 has received a US patent allowance.